NT-proBNP content in seminal plasma of ejaculate in normal conditions and in oligozooastenospermia

Abstract

Objective. To investigate the NT-proBNP concentration in ejaculate samples from healthy men and men with oligozooastenospermia.

Materials and methods. The study included 52 men of reproductive age (34.4 ± 3.9 years). The main group (n = 18) consisted of men with reduced ejaculate fertility, the comparison group (n = 34) consisted of men with normal levels of concentration and total sperm count. In seminal plasma, the concentration of NT-proBNP was investigated by solid-phase ELISA using the NT-proBNP-ELISA-BEST test system (A-9102) (Vector-Best, Russia).

Results. The mean value of NT-proBNP content in the ejaculate (n = 52) was 29.498 pg / ml, the median concentration was 2.860 pg / ml and was characterized by high variability. In 62% (32 of 52) of the tested seminal plasma samples, the NT-proBNP value was below 20 pg / ml. The frequency of samples with such a low NT-proBNP content did not differ statistically significantly between the groups. In the main group, the number of such samples was 44 % (8 samples out of 18), and in the comparison group, 65 % (12 samples out of 34).

Conclusions. When comparing the content of NT-proBNP in seminal plasma, no statistically significant differences were found between the groups. An analysis of the correlation between the concentration and the number of sperm in the ejaculate and the NT-proBNP content also did not reveal a statistically significant relationship. The possible role of natriuretic peptides in human fertility is discussed.

Keywords

Brain natriuretic peptide / NT-proBNP / ejaculate / seminal plasma / oligozooastenospermia / male infertility

References

[1] Deshpande P.S., Gupta A.S. Causes and Prevalence of Factors Causing Infertility in a Public Health Facility. J Hum Reprod Sci 2019; 12 (4): 287–293. DOI: 10.4103/jhrs.JHRS_140_18

[2] Deshpande P.S., Gupta A.S. Causes and Prevalence of Factors Causing Infertility in a Public Health Facility. J Hum Reprod Sci 2019; 12 (4): 287–293.

[3] Lebedev G.S., Golubev N.A., Shaderkin I.A., Shaderkina V.A., Apolikhin O.I., Sivkov A.V., Komarova V.A. Male infertility in the Russian Federation: statistical data for 2000–2018. Experimental and clinical urology 2019; 4: 4–12 (in Russian). DOI: 10.29188/2222-8543-2019-11-4-4-12

[4] Лебедев Г.С., Голубев Н.А., Шадеркин И.А., Шадеркина В.А., Аполихин О.И., Сивков А.В., Комарова В.А. Мужское бесплодие в Российской Федерации: статистические данные за 2000 – 2018 годы. Экспериментальная и клиническая урология 2019; 4: 4–12.

[5] Sulima A.N., Litvinov V.V., Klimenko P.M., Starovoitov E.L., Kolesnikova I.O. Features of male infertility as the only factor in infertility of a married couple in the ART clinic. Experimental and clinical urology 2019; 4: 68–73 (in Russian). DOI: 10.29188/2222-8543-2019-11-4-68-73

[6] Сулима А.Н., Литвинов В.В., Клименко П.М., Старовойтов Э.Л., Колесникова И.О. Особенности мужской инфертильности как единственного фактора бесплодия супружеской пары в клинике ВРТ. Экспериментальная и клиническая урология 2019; 4: 68–73.

[7] Kachura D.V., Volchek V.A., Kuchumova N.Yu., Gal'kovic K.R. A case of ultrasound diagnosis of epididymal fibroids. Ul'trazvukovaya i funktsion diagnostika 2007; 4: 175 (in Russian).

[8] Качура Д.В., Волчек В.А., Кучумова Н.Ю., Галькович К.Р. Случай ультразвуковой диагностики фибромы придатка яичка. Ультразвуковая и функциональная диагностика 2007; 4: 175.

[9] Nassiri N., English M., Lashkari N., Wei J., Samplaski M.K. Reproductive Urologist and Gynecologist Involvement in Postvasectomy Sperm Retrieval Procedures at American Fertility Clinics. Urology 2019; 133: 116–120. DOI: 10.1016/j.urology.2019.08.019

[10] Nassiri N., English M., Lashkari N., Wei J., Samplaski M.K. Reproductive Urologist and Gynecologist Involvement in Postvasectomy Sperm Retrieval Procedures at American Fertility Clinics. Urology 2019; 133: 116–120.

[11] Kobori Y. Home Testing for Male Factor Infertility: A Review of Current Options. Fertil Steril 2019; 111 (5): 864–870. DOI: 10.1016/j.fertnstert.2019.01.032 Review.

[12] Kobori Y. Home Testing for Male Factor Infertility: A Review of Current Options. Fertil Steril 2019; 111 (5): 864–870.

[13] Druart X., de Graaf S. Seminal Plasma Proteomes and Sperm Fertility. Anim Reprod Sci 2018; 194: 33–40. DOI: 10.1016/j.anireprosci.2018.04.061 Review.

[14] Druart X, de Graaf S. Seminal Plasma Proteomes and Sperm Fertility. Anim Reprod Sci 2018; 194: 33–40.

[15] Sosnin D.Yu., Gal'kovich K.R. Vasculoendothelial growth factor and ejaculate fertility. Laboratornaya sluzhba 2020; 9 (1): 84–89 (in Russian). DOI: 10.17116/labs2020901184

[16] Соснин Д.Ю., Галькович К.Р. Васкулоэндотелиальный фактор роста и фертильность эякулята. Лабораторная служба 2020; 9 (1): 84–89.

[17] Sosnin D.Yu., Zubareva N.A., Nenashe- va O.Yu., Krivtsov A.V., Karimova N.V., Pozdin N.V. The concentration of procalcitonin in the ejaculate and serum of healthy men and men with oligozooasthenospermia. Urologiya 2017; 1: 61–65 (in Russian). DOI: 10.18565/urol.2017.1.61-65.

[18] Соснин Д.Ю., Зубарева Н.А., Ненашева О.Ю., Кривцов А.В., Каримова Н.В., Поздин Н.В. Кронцентрация прокальцитонина в эякуляте и сыворотке крови здоровых мужчин и мужчин с олигозооастеноспермией. Урология 2017; 1: 61–65.

[19] Candemir M., Şahinarslan A., Yazol M., Öner Y.A., Boyacı B. Determination of Myocardial Scar Tissue in Coronary Slow Flow Phenomenon and The Relationship Between Amount of Scar Tissue and Nt-ProBNP. Arq Bras Cardiol 2020; 114 (3): 540–551. DOI: 10.36660/abc.2018149

[20] Candemir M., Şahinarslan A., Yazol M., Öner Y.A., Boyacı B. Determination of Myocardial Scar Tissue in Coronary Slow Flow Phenomenon and The Relationship Between Amount of Scar Tissue and Nt-ProBNP. Arq Bras Cardiol 2020; 114 (3): 540–551.

[21] Sosnin D.Yu., Gavrilova T.V., Larin A.E., Nenasheva O.Yu., Krivtsov A.V., Chereshneva M.V. The concentration of cerebral natriuretic peptide in tear and blood serum. Klinicheskaya Laboratornaya Diagnostika (Russian Clinical Laboratory Diagnostics) 2017; 62 (12): 719–724 (in Russian). DOI: 10.18821/0869-2084-2017-62-12-719-724

[22] Соснин Д.Ю., Гаврилова Т.В., Ларин А.Э., Ненашева О.Ю., Кривцов А.В, Черешнева М.В. Концентрация мозгового натрийуретического пептида в слезе и сыворотке крови. Клиническая лабораторная диагностика 2017; 62 (12): 719–724.

[23] Sosnin D.Yu., Gileva O.S., Mozgovaia L.A., Sivak E.Yu., Beleva N.S., Krivtsov A.V., Pozdin N.V. The NT-proBNP in saliva and blood serum in norm and under periodontitis. Klinicheskaya Laboratornaya Diagnostika (Russian Clinical Laboratory Diagnostic) 2018; 63 (3): 164–168. (in Russian). DOI: 10.18821/0869-2084-2018-63-3-164-168

[24] Соснин Д.Ю., Гилева О.С., Мозговая Л.А., Сивак Е.Ю., Белева Н.С., Кривцов А.В., Поздин Н.В. NT-proBNP в слюне и сыворотке крови в норме и при пародонтите. Клиническая лабораторная диагностика 2018; 63 (3): 164–168.

[25] Abdul Rehman S., Khurshid Z., Hussain Niazi F., Naseem M., Al Waddani, Sahibzada H.A., Sannam Khan R. Role of salivary bio- markers in detection of cardiovascular disease (CVD). Proteomes 2017; 5 (3): pii E21. DOI: 10.3390/proteomes5030021

[26] Abdul Rehman S., Khurshid Z., Hussain Niazi F., Naseem M., Al Waddani, Sahibzada H.A., Sannam Khan R. Role of salivary bio-markers in detection of cardiovascular disease (CVD). Proteomes 2017; 5 (3): pii E21.

[27] Naeem B., Ayub A., Aly A.M., Malloy M.H., Okorodudu A.O., Jain S.K. Urinary NT-proBNP as a potential noninvasive biomarker for screening of pulmonary hypertension in preterm infants: a pilot study. J Perinatol 2020; 40 (4): 628–632. DOI: 10.1038/s41372-019-0581-9

[28] Naeem B., Ayub A., Aly A.M., Malloy M.H., Okorodudu A.O., Jain S.K. Urinary NT-proBNP as a potential noninvasive biomarker for screening of pulmonary hypertension in preterm infants: a pilot study. J Perinatol 2020; 40 (4): 628–632.

[29] WHO Laboratory manual for the xamination and processing of human semen. Trans. from English by N.P. Makarov. Scientific ed. by L.F. Kurilo. 5th ed. Moscow: Kapital Print 2012 (In Russian).

[30] Руководство ВОЗ по исследованию и обработке эякулята человека. Пер. с англ. Н.П. Макарова. Науч. ред. Л.Ф. Курило. 5-е изд. М.: Капитал Принт 2012.

[31] Xia H., Chen Y., Wu K.J., Zhao H., Xiong C.L., Huang D.H. Role of C-type natriuretic peptide in the function of normal human sperm. Asian J Androl 2016; 18 (1): 80–84. DOI: 10.4103/1008-682X.150254

[32] Xia H., Chen Y., Wu K.J., Zhao H., Xiong C.L., Huang D.H. Role of C-type natriuretic peptide in the function of normal human sperm. Asian J Androl 2016; 18 (1): 80–84.

[33] Volpe M., Rubattu S., Burnett J. Jr. Natriuretic peptides in cardiovascular diseases: current use and perspectives. Eur Heart J 2014; 35 (7): 419–425. DOI:10.1093/eurheartj/eht466

[34] Volpe M., Rubattu S., Burnett J. Jr. Natriuretic peptides in cardiovascular diseases: current use and perspectives. Eur Heart J 2014; 35 (7): 419–425.

[35] Golukhova E.Z., Teryaeva N.B., Alieva A.M. Natriuretic peptides-markers and prognostic factors in chronic heart failure. Kreativnaya kardiologiya 2007; 1–2: 126–136 (in Russian).

[36] Голухова Е.З., Теряева Н.Б., Алиева А.М. Натрийуретические пептиды – маркеры и факторы прогноза при хронической сердечной недостаточности. Креативная кардиология 2007; 1–2: 126–136.

[37] Nishikimi T., Kuwahara K., Nakao K. Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides. J Cardiol 2011; 57: 131–40. DOI: 10.1016/j.jjcc.2011.01.002

[38] Nishikimi T., Kuwahara K., Nakao K. Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides. J Cardiol 2011; 57: 131–140.

[39] Potter L.R., Yoder A.R., Flora D.R., Antos L.K., Dickey D.M. Natriuretic peptides: their structures, receptors, physiologic func-tions and therapeutic applications. Handb Exp Pharmacol 2009; 191: 341–366. DOI: 10.1007/978-3-540-68964-5_15

[40] Potter L.R., Yoder A.R., Flora D.R., Antos L.K., Dickey D.M. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol 2009; 191: 341–366.

[41] Koller K.J., Lowe D.G., Bennett G.L., Minamino N., Kangawa K., Matsuo H., Goeddel D.V. Selective activation of the B natriuretic peptide receptor by C‐type natriuretic peptide (CNP). Science 1991; 252: 120–123. DOI: 10.1126/science.1672777

[42] Koller K.J., Lowe D.G., Bennett G.L., Minamino N., Kangawa K., Matsuo H., Goeddel D.V. Selective activation of the B natriuretic peptide receptor by C‐type natriuretic peptide (CNP). Science 1991; 252: 120–123.

[43] Salzmann J., Flitcroft D., Bunce C., Gordon D., Wormald R., Migdal C. Brain natriuretic peptide: identification of a second natriuretic peptide in human aqueous humour. Br J Ophthalmol 1998; 82 (7): 830–834. DOI: 10.1136/bjo.82.7.830

[44] Salzmann J., Flitcroft D., Bunce C., Gordon D., Wormald R., Migdal C. Brain natriuretic peptide: identification of a second natriuretic peptide in human aqueous humour. Br J Ophthalmol 1998; 82 (7): 830–834.

[45] Foo J.Y., Wan Y., Kostner K., Arivala- gan A., Atherton J., Cooper-White J., Dimeski G., Punyadeera C. NT-ProBNP levels in saliva and its clinical relevance to heart failure. PLoS One 2012; 7 (10): e48452. DOI: 10.1371/journal.pone.0048452.

[46] Foo J.Y., Wan Y., Kostner K., Arivalagan A., Atherton J., Cooper-White J., Dimeski G., Punyadeera C. NT-ProBNP levels in saliva and its clinical relevance to heart failure. PLoS One 2012; 7 (10): e48452.

[47] Hodes A., Lichtstein D. Natriuretic hormones in brain function. Front Endocrinol (Lausanne) 2014; 5: 201. DOI: 10.3389/fendo.2014.00201

[48] Hodes A., Lichtstein D. Natriuretic hormones in brain function. Front Endocrinol (Lausanne) 2014; 5: 201.

[49] Milevoj Kopcinovic L., Culej J., Jokic A., Bozovic M., Kocijan I. Laboratory testing of extravascular body fluids: National recommendations on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Part I-Serous fluids. Biochem Med (Zagreb) 2020; 30 (1): 010502. DOI:10.11613/BM.2020.010502

[50] Milevoj Kopcinovic L., Culej J., Jokic A., Bozovic M., Kocijan I. Laboratory testing of extravascular body fluids: National recommendations on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Part I – Serous fluids. Biochem Med (Zagreb) 2020; 30 (1): 010502.

[51] Zakeri R., Sangaralingham S.J., Sandberg S.M., Heublein D.M., Scott C.G., Burnett J.C. Jr. Urinary C-type natriuretic peptide: a new heart failure biomarker. JACC Heart Fail 2013; 1 (2): 170–177. DOI: 10.1016/j.jchf.2012.12.003

[52] Zakeri R., Sangaralingham S.J., Sandberg S.M., Heublein D.M., Scott C.G., Burnett J.C. Jr. Urinary C-type natriuretic peptide: a new heart failure biomarker. JACC Heart Fail 2013; 1 (2): 170–177.

[53] Walther T., Stepan H. C‐type natriuretic peptide in reproduction, pregnancy and fetal development. J Endocrinol 2004; 180: 17–22. DOI: 10.1677/joe.0.1800017

[54] Walther T., Stepan H. C‐type natriuretic peptide in reproduction, pregnancy and fetal development. J Endocrinol 2004; 180: 17–22.

[55] Collin O., Lissbrant E., Bergh A. Atrial natriuretic peptide, brain natriuretic peptide and c type natriuretic peptide: effects on testicular microcirculation and immunohistochemical localization. Int J Androl 1997; 20: 55–60. DOI: 10.1046/j.1365-2605.1997.00108.x

[56] Collin O., Lissbrant E., Bergh A. Atrial natriuretic peptide, brain natriuretic peptide and c type natriuretic peptide: effects on testicular microcirculation and immunohistochemical localization. Int J Androl 1997; 20: 55–60.

RIGHTS & PERMISSIONS

Sosnin D.Y., Galkovich K.R., Krivtsov A.V.